JP Morgan Chase’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,931
Closed -$262K 7684
2024
Q1
$262K Sell
5,931
-41,222
-87% -$1.88M ﹤0.01% 5196
2023
Q4
$2.17M Buy
+47,153
New +$2.01M ﹤0.01% 3782
2023
Q3
Sell
-94,306
Closed -$4.5M 7677
2023
Q2
$4.5M Buy
+94,306
New +$4.55M ﹤0.01% 2940
2021
Q4
Sell
-47,153
Closed -$2.58M 6902
2021
Q3
$2.58M Hold
47,153
﹤0.01% 3569
2021
Q2
$2.42M Hold
47,153
﹤0.01% 3658
2021
Q1
$2.44M Sell
47,153
-29,706
-39% -$1.63M ﹤0.01% 3565
2020
Q4
$4.31M Buy
+76,859
New +$4.1M ﹤0.01% 2934

Other funds holding QGEN

JP Morgan Chase's QGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Qiagen (QGEN) stake by 42% in Q1 2026, selling an estimated $17.8M and leaving 511,485 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

JP Morgan Chase first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $236M in Q1 2020. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • JP Morgan Chase held 511,485 shares of Qiagen worth $20.1M as of Q1 2026.
  • JP Morgan Chase sold 375,337 Qiagen shares in Q1 2026, an estimated $17.8M.
  • Qiagen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2064 holding.
  • JP Morgan Chase first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • JP Morgan Chase's Qiagen position peaked at $236M in Q1 2020.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.